Extended-Release Guanfacine Does Not Show a Large Effect on Tic Severity in Children with Chronic Tic Disorders

Overview of attention for article published in Journal of Child & Adolescent Psychopharmacology, November 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 4 news stories from 4 outlets.

A new study assessed the safety, tolerability, and effectiveness of extended-release guanfacine in children 6-17 years of age…

New Rochelle, NY — A new study assessed the safety, tolerability, and effectiveness of extended-release guanfacine in children 6…

Printer friendly versionShare 26 July 2017 Mary Ann Liebert, Inc., Publishers A new study assessed the safety, tolerability…

New Rochelle, N.Y., July 26, 2017--A new study assessed the safety, tolerability, and effectiveness of extended-release…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.